Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) Shares Sold by Rosalind Advisors Inc.

Rosalind Advisors Inc. lowered its stake in Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) by 2.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 250,555 shares of the company’s stock after selling 5,000 shares during the quarter. Kiora Pharmaceuticals comprises 0.4% of Rosalind Advisors Inc.’s portfolio, making the stock its 25th largest position. Rosalind Advisors Inc. owned about 0.08% of Kiora Pharmaceuticals worth $827,000 as of its most recent filing with the SEC.

Kiora Pharmaceuticals Price Performance

Kiora Pharmaceuticals stock opened at $3.29 on Friday. Kiora Pharmaceuticals, Inc. has a one year low of $2.91 and a one year high of $6.48. The stock’s 50 day moving average price is $3.51 and its 200 day moving average price is $3.49.

About Kiora Pharmaceuticals

Kiora Pharmaceuticals, Inc, a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1b clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases.